Guidance Updated for Fiscal Year 2023
The Company is updating its initial financial guidance for fiscal year 2023, as follows:
Net revenue of $3.160 billion to $3.240 billion (previously $3.210 billion to $3.290 billion);
Adjusted EBITDA of $650 million to $710 million (previously $690 million to $750 million);
Total capital expenditures representing 10-12% of net revenue (previously 9-11% of net revenue).
Guidance for fiscal year 2023 does not include any contributions from acquisitions that have not yet closed.
Conference Call
Management will host a conference call at 8:30 am ET tomorrow to discuss the results and business activities. Interested parties may participate in the call by dialing:
(800) 245-3047 (Domestic) or
(203) 518-9765 (International)
When prompted, reference Conference ID: AHCO4Q22
Webcast registration: Click Here
Following the live call, a replay will be available for six months on the Company's website,www.adapthealth.com under "Investor Relations."
https://finance.yahoo.com/news/adapthealth-corp-announces-fourth-quarter-222800572.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.